MA43791A - Composés de carbapénème - Google Patents

Composés de carbapénème

Info

Publication number
MA43791A
MA43791A MA043791A MA43791A MA43791A MA 43791 A MA43791 A MA 43791A MA 043791 A MA043791 A MA 043791A MA 43791 A MA43791 A MA 43791A MA 43791 A MA43791 A MA 43791A
Authority
MA
Morocco
Prior art keywords
carbapenem compounds
carbapenem
compounds
Prior art date
Application number
MA043791A
Other languages
English (en)
Inventor
Gopalan Balasubramanian
Manjula Devi Deshkumar
Shuzhi Dong
Prabhakar Rao Gunturu
Sridhar Ramanathan Iyer
Venkateshwarlu Jakkala
Michael Miller
Ravi P Nargund
Venkatesan Parameswaran
Maneesh Paul-Satyaseela
Hariharan Periasamy
Sheo Singh
Chidambaram Venkateswaran Srinivasan
Bharani Thirunavukkarasu
Hongwu Wang
Katherine Young
Original Assignee
Merck Sharp & Dohme
Orchid Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme, Orchid Pharma Ltd filed Critical Merck Sharp & Dohme
Publication of MA43791A publication Critical patent/MA43791A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
MA043791A 2016-03-16 2017-03-15 Composés de carbapénème MA43791A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN201641009127 2016-03-16

Publications (1)

Publication Number Publication Date
MA43791A true MA43791A (fr) 2018-11-28

Family

ID=58715155

Family Applications (1)

Application Number Title Priority Date Filing Date
MA043791A MA43791A (fr) 2016-03-16 2017-03-15 Composés de carbapénème

Country Status (12)

Country Link
US (1) US11180504B2 (fr)
EP (1) EP3430013B1 (fr)
JP (1) JP7213173B2 (fr)
KR (1) KR102435777B1 (fr)
CN (1) CN109415365B (fr)
AU (1) AU2017235293B2 (fr)
CA (1) CA3015309C (fr)
IL (1) IL261782B2 (fr)
MA (1) MA43791A (fr)
MX (1) MX2018011095A (fr)
WO (1) WO2017158616A1 (fr)
ZA (1) ZA201805158B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020027553A1 (fr) * 2018-08-03 2020-02-06 한양대학교 에리카산학협력단 Sonde pour la détection de bactéries résistantes au carbapénème et utilisation correspondante
EP4377321A1 (fr) * 2021-07-28 2024-06-05 University of KwaZulu-Natal Inhibiteurs de métallo-?-lactamases
TW202413352A (zh) * 2022-06-13 2024-04-01 日商模數探索股份有限公司 氮雜環烷基羰基環狀胺化合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194047A (en) 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
EP0082133A3 (en) 1979-04-19 1983-07-20 Merck & Co. Inc. A process for preparing intermediates useful for preparing 2-substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids
EP0044170A1 (fr) 1980-07-11 1982-01-20 Beecham Group Plc Antibiotiques bêta-lactame, leur préparation et leur utilisation
JPS57158785A (en) 1981-02-27 1982-09-30 Beecham Group Ltd Beta-lactam antibiotic, manufacture and medicinal composition
EP0059554A3 (fr) 1981-02-27 1982-10-20 Beecham Group Plc Antibiotiques bêta-lactame, un procédé pour leur préparation et leur application en compositions pharmaceutiques
CA1283906C (fr) 1983-05-09 1991-05-07 Makoto Sunagawa COMPOSE DE .beta.-LACTAM ET PROCEDE DE PRODUCTION
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
JPS6383062A (ja) * 1986-09-26 1988-04-13 Nippon Redarii Kk アゼチジンスルホン酸誘導体
CA2004798A1 (fr) 1988-12-09 1990-06-09 Jacques Banville 6-aminoalkyl carbapenemes
JPH04211083A (ja) * 1990-02-23 1992-08-03 Sankyo Co Ltd カルバペネム−３−カルボン酸誘導体
JP2934283B2 (ja) * 1990-05-29 1999-08-16 第一製薬株式会社 カルバペネム誘導体
NO302475B1 (no) 1991-06-04 1998-03-09 Sankyo Co 1-metylkarbapenemderivater og farmasöytisk preparat inneholdende disse
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
GB9202298D0 (en) 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
JP3411589B2 (ja) * 1992-05-11 2003-06-03 第一製薬株式会社 カルバペネム誘導体
US5602118A (en) 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
JP3199300B2 (ja) 1994-05-09 2001-08-13 三共株式会社 １−メチルカルバペネム誘導体

Also Published As

Publication number Publication date
JP7213173B2 (ja) 2023-01-26
CN109415365A (zh) 2019-03-01
WO2017158616A8 (fr) 2018-06-07
ZA201805158B (en) 2023-01-25
IL261782B1 (en) 2024-03-01
IL261782A (en) 2018-10-31
KR20180133420A (ko) 2018-12-14
JP2019512547A (ja) 2019-05-16
AU2017235293B2 (en) 2021-02-04
IL261782B2 (en) 2024-07-01
US20200291029A1 (en) 2020-09-17
EP3430013A1 (fr) 2019-01-23
US11180504B2 (en) 2021-11-23
CA3015309C (fr) 2024-02-13
CN109415365B (zh) 2022-08-09
BR112018068462A2 (pt) 2019-01-22
CA3015309A1 (fr) 2017-09-21
EP3430013B1 (fr) 2023-11-15
RU2018136064A3 (fr) 2020-04-16
AU2017235293A1 (en) 2018-08-23
KR102435777B1 (ko) 2022-08-23
MX2018011095A (es) 2019-01-10
RU2018136064A (ru) 2020-04-16
WO2017158616A1 (fr) 2017-09-21

Similar Documents

Publication Publication Date Title
MA42293A (fr) Composés antibactériens
MA47131A (fr) Composés benzyl-amide phosphodiamide antiviraux
MA49701A (fr) Composés immunomodulateurs
MA44233A (fr) Nouveaux composés
MA44050A (fr) Nouveaux composés
MA41614A (fr) Composés antiviraux
DE112017004654A5 (de) Applikator
MA52948A (fr) Composés
MA46242A (fr) Composés inhibiteurs de bêta-lactamase
MA51669A (fr) Composés
MA53003A (fr) Composés
DK4039675T3 (da) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser
MA45221A (fr) Nouveaux composés antibactériens
DE112017002364A5 (de) Wellgetriebe
CL2016002165A1 (es) Compuestos de aminocarbonilcarbamato
MA44020A (fr) Composés antitumoraux
MA50504A (fr) Composés antibactériens
BR112017002508A2 (pt) novos compostos substituídos com halogênio
DK3597189T3 (da) Krystallinske forbindelser
DK3183242T3 (da) Substituerede bicykliske forbindelser
MA49522A (fr) Nouveaux composés de quinoléinone
DK3347403T3 (da) Polyalkoxyfedtforbindelse
MA42034A (fr) Composés pipéridiniques tricycliques
MA52946A (fr) Composés
MA51221A (fr) Composés de pyrazolopyridinone